Article Details

Gemini Therapeutics (NASDAQ:GMTX) Cut to "Hold" at Zacks Investment Research | MarketBeat

Retrieved on: 2021-12-12 04:12:09

Tags for this article:

Click the tags to see associated articles and topics

Gemini Therapeutics (NASDAQ:GMTX) Cut to "Hold" at Zacks Investment Research | MarketBeat. View article details on hiswai:

Excerpt

Zacks Investment Research cut shares of Gemini Therapeutics from a "buy" rating to a "hold" rating in a research note on Friday.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up